Department of Manufacturing Pharmacy, College of Pharmacy, Rangsit University, Pathum Thani, 12000, Thailand.
Department of Industrial Pharmacy, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, 73000, Thailand.
Int J Nanomedicine. 2023 Dec 21;18:7889-7900. doi: 10.2147/IJN.S433756. eCollection 2023.
Chitosan nanoparticles have garnered considerable interest in the field of drug delivery owing to their distinctive properties, including biocompatibility, biodegradability, low toxicity, and ability to encapsulate a wide range of drugs. However, the conventional methods (eg, the drop method) for synthesizing chitosan nanoparticles often face limitations in regard to controlling the particle size, morphology, and scalability, hindering their extensive application in drug delivery systems. To overcome these challenges, this study explores using a novel flow chemistry reactor design for fabricating clindamycin-loaded chitosan nanoparticles.
By varying two critical operating parameters of flow chemistry, namely, the flow rate ratio and total flow rate, the impact of these parameters on the properties of chitosan nanoparticles is investigated using a central composite experimental design.
The optimized conditions for nanoparticle preparation yielded remarkable results, with chitosan nanoparticles exhibiting a small size of 371.60 nm and an extremely low polydispersity index of 0.042. Furthermore, using novel design flow chemistry reactor, the productivity of chitosan nanoparticles was estimated to be 25,402.17 mg/min, which was ~12.71 times higher than that obtained via batch synthesis.
The findings of this study indicate that the use of novel design flow chemistry reactor is promising for synthesizing clindamycin-loaded chitosan nanoparticles and other polymeric nanoparticles intended for drug delivery applications. This is primarily attributed to their ability to produce nanoparticles with a considerably reduced particle size distribution and smaller overall size. The demonstrated high productivity of this technique suggests the potential for industrial-scale nanoparticle manufacturing.
壳聚糖纳米粒子因其独特的性质,包括生物相容性、可生物降解性、低毒性和能够封装广泛的药物,在药物传递领域引起了相当大的关注。然而,合成壳聚糖纳米粒子的传统方法(例如,滴注法)在控制颗粒尺寸、形态和可扩展性方面常常受到限制,阻碍了它们在药物传递系统中的广泛应用。为了克服这些挑战,本研究探索了使用新型流动化学反应器设计来制备克林霉素负载的壳聚糖纳米粒子。
通过改变流动化学的两个关键操作参数,即流速比和总流速,使用中心复合实验设计研究这些参数对壳聚糖纳米粒子性质的影响。
优化的纳米粒子制备条件产生了显著的结果,壳聚糖纳米粒子的尺寸小至 371.60nm,多分散指数极低,为 0.042。此外,使用新型设计的流动化学反应器,壳聚糖纳米粒子的生产率估计为 25402.17mg/min,约比批合成法高 12.71 倍。
本研究的结果表明,新型设计流动化学反应器在合成克林霉素负载壳聚糖纳米粒子和其他用于药物传递应用的聚合物纳米粒子方面具有应用前景。这主要归因于它们能够生产具有显著减小的颗粒尺寸分布和更小整体尺寸的纳米粒子。该技术展示的高生产率表明了其在工业规模纳米粒子制造方面的潜力。